WO2004043313A2 - Device for the extravascular recirculation of liquid in body cavities - Google Patents

Device for the extravascular recirculation of liquid in body cavities Download PDF

Info

Publication number
WO2004043313A2
WO2004043313A2 PCT/CA2003/001732 CA0301732W WO2004043313A2 WO 2004043313 A2 WO2004043313 A2 WO 2004043313A2 CA 0301732 W CA0301732 W CA 0301732W WO 2004043313 A2 WO2004043313 A2 WO 2004043313A2
Authority
WO
WIPO (PCT)
Prior art keywords
liquid
cavity
catheter
temperature
pressure
Prior art date
Application number
PCT/CA2003/001732
Other languages
French (fr)
Other versions
WO2004043313A3 (en
Inventor
Ross E. Mantle
Original Assignee
Mantle Ross E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mantle Ross E filed Critical Mantle Ross E
Priority to AU2003281888A priority Critical patent/AU2003281888A1/en
Priority to US10/523,857 priority patent/US7842002B2/en
Publication of WO2004043313A2 publication Critical patent/WO2004043313A2/en
Publication of WO2004043313A3 publication Critical patent/WO2004043313A3/en
Priority to US12/916,076 priority patent/US20110046547A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/12Devices for heating or cooling internal body cavities
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor
    • A61M1/1656Apparatus for preparing dialysates
    • A61M1/166Heating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/168Sterilisation or cleaning before or after use
    • A61M1/1686Sterilisation or cleaning before or after use by heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/281Instillation other than by gravity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/285Catheters therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32Oxygenators without membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00Medical syringes, e.g. enemata; Irrigators
    • A61M3/02Enemata; Irrigators
    • A61M3/0233Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs
    • A61M3/0254Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped
    • A61M3/0258Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped by means of electric pumps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0059Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit
    • A61F2007/0069Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit with return means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/12Devices for heating or cooling internal body cavities
    • A61F2007/126Devices for heating or cooling internal body cavities for invasive application, e.g. for introducing into blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687Chemical treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026Multi-lumen catheters with stationary elements
    • A61M25/003Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves
    • A61M2025/0031Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves characterized by lumina for withdrawing or delivering, i.e. used for extracorporeal circuit treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026Multi-lumen catheters with stationary elements
    • A61M2025/0037Multi-lumen catheters with stationary elements characterized by lumina being arranged side-by-side
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/36General characteristics of the apparatus related to heating or cooling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/50Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
    • A61M27/002Implant devices for drainage of body fluids from one part of the body to another
    • A61M27/006Cerebrospinal drainage; Accessories therefor, e.g. valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00Medical syringes, e.g. enemata; Irrigators
    • A61M3/02Enemata; Irrigators
    • A61M3/0202Enemata; Irrigators with electronic control means or interfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00Medical syringes, e.g. enemata; Irrigators
    • A61M3/02Enemata; Irrigators
    • A61M3/0229Devices operating in a closed circuit, i.e. recycling the irrigating fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/44Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for cooling or heating the devices or media

Definitions

  • This invention relates to processes and devices for automated extracorporeal recirculation and chemical manipulation of biological and biocompatible liquids such as for example cerebrospinal fluid, artificial cerebrospinal fluid, saline, and Ringer's lactate in body cavities for the purposes of prevention or treatment of a variety of disorders.
  • biological and biocompatible liquids such as for example cerebrospinal fluid, artificial cerebrospinal fluid, saline, and Ringer's lactate in body cavities for the purposes of prevention or treatment of a variety of disorders.
  • CSF cerebrospinal fluid
  • Ischemia of the intestine or colon in which hypothermia might protect the tissues from ischemic damage. Such protection may apply in other organs subject to ischemia, such as the heart.
  • hypothermia applied during injuries has been extensively documented, and is currently in use intraoperatively in certain forms of brain surgery and cardiac surgery.
  • hypothermia has been shown to be effective when applied contemporaneously with the injury in both brain trauma and brain ischemia in animals in a large number of studies. Disappointing early results with delayed hypothermia, and the resultant widespread notion of a narrow 'therapeutic window' dampened enthusiasm in this area for many years. Recent reports suggest that much longer hypothermic times than were previously contemplated can compensate for delays in treatment and produce outcomes comparable to contemporaneous hypothermia.
  • Intra-arterial cooling using either bypass- cooled blood or intra-arterial cooling probes.
  • Intra-arterial approaches suffer from the major inherent risk of endovascular instrumentation of the cranial arteries; that of precipitating stroke. To minimize this risk, such instrumentation is normally done under full dose heparin anticoagulation, which may be contraindicated in both trauma and stroke due to the risk of bleeding.
  • CSF cerebrospinal fluid
  • CSF CSF to the lumbar cistern by reversal of flow using a single reciprocating pump.
  • This system seems intended primarily for the removal of subarachnoid blood from the CSF in the context of subarachnoid hemorrhage.
  • 10 ml of CSF are exchanged in 25 s cycles, giving a flow rate of 24 ml/min. If the temperature of the returned CSF is at 4°C, this flow rate may not be adequate to achieve significant cooling in the spinal cord, where published flows of approximately 30 ml/min were required in a human trial (Davison e al., 1994).
  • US patent no. 6,379,331 discloses another medical device for intrathecal cooling of the spinal cord in which separate inflow and outflow catheters are inserted into the CSF spaces of the spinal cord such that their tips are at the extremities of the cavity to be cooled.
  • CSF is extracted from one catheter, cooled, and returned to the second catheter by means of a single pump without automated feedback control.
  • the flow rate of the single pump is adjusted to keep intraspinal pressure (as estimated from the pressure of the extracorporeal fluid, and not from measurement within the cavity) below a safe level.
  • This system is intended primarily for the special case of intraoperative spinal cord cooling in the context of abdominal aortic aneurysm surgery and provides no means of continued cooling over 24 h or more, as required for delayed hypothermia to be effective.
  • Alternate placement of one of the catheters into the lateral ventricle of the brain is disclosed as a method of cooling the brain, although practical brain cooling would seem unlikely due to flow rate limitations.
  • a difficulty with any catheter arrangement in which the catheter tips are separated in space is that pressure differentials may occur between the inflow and outflow regions at higher flow rates.
  • the maximal flow is limited by the maximal safe pressure in the region of the inflow catheter, where pressure is high, and minimal safe pressure in the region of the outflow catheter, where pressure is low.
  • Placement of two catheters in the brain ventriclular system such that their tips are relatively close together suffers from the disadvantage of having to pierce the brain twice, doubling the risk of intraparenchymal hemorrhage due to catheter placement.
  • US patent no. 4,445,500 discloses a treatment for stroke involving the recirculation of an oxygenated perfluorocarbon emulsion in the subarachnoid (CSF) space.
  • This system is intended to counteract ischemic injuries of the central nervous system by providing sufficient oxygen in the perfusate to allow continued tissue metabolism in the face of insufficient blood flow.
  • the system depends on an involved process for the manufacture and maintenance of the perfluorocarbon emulsion, which is a fluid whose biocompatibility would need to be established.
  • a single pump is again used for circulation of the fluid within the subarachnoid space, which precludes active pressure modulation, and the inflow and outflow catheters are separated.
  • Devices for recirculation of liquids in the peritoneal cavity have been disclosed in, for example, US patent no. 6254567, 6409699, and 5141493. These devices are dialysate circulators for the purpose of continuous flow-through intraperitoneal dialysis (CFPD) used in the treatment of kidney or liver failure. Many of these designs incorporate a heater whose purpose is to warm the dialysate to body temperature before it enters the body, but therapeutic temperature modulation is not encompassed. They generally feature a means of maintaining constant pressure of the dialysate fluid extracorporeally, but do not accomplish pressure modulation within the cavity by use of independent inflow and outflow pumps. These devices are also not intended for the delivery of drugs or the removal of contaminants such as blood or pus.
  • CFPD continuous flow-through intraperitoneal dialysis
  • Foam fractionation is a technique for the removal of proteins and other contaminants from a liquid. This technique is used in marine aquaculture, where it is commonly known as 'protein skimming'. Dissolved amphipathic (partly water soluble and partly non-water soluble) molecules such as proteins tend to accumulate at an air/water interface since part of the molecule is more stable when dissolved in aqueous solution and part is more stable in air. Such molecules can be removed with high efficiency from liquids with favorable physical properties by saturation of the solution with fine bubbles. The bubbles accumulate proteins at the air/water interface and the resulting foam rises to the top of the liquid, where it may be collected or skimmed off. As an additional benefit, the intimate contact of air or of a gas mixture containing oxygen can oxygenate the liquid.
  • a process and device are disclosed for liquid recirculation to and from a body cavity (eg. subarachnoid space, cerebral ventricular system, mediastinum, pleural space, peritoneum).
  • a body cavity eg. subarachnoid space, cerebral ventricular system, mediastinum, pleural space, peritoneum.
  • a two channel catheter is used where one channel inserts liquid and the other removes it.
  • One or more secondary drainage catheters may also be inserted as needed to enhance the distribution of the liquid within the cavity.
  • the device allows control of the temperature and pressure of the liquid over short or long time periods (hours to days) according to predetermined protocols. Further preferred embodiments permit manipulation of the liquid, such as dilution with artificial liquids, removal of contaminants by foam fractionation, oxygenation, pH balancing, and addition of chemical agents or drugs.
  • a process and device for removal of body liquids, treatment of them by foam fractionation and optional other processes, and their return to the body cavity from which they came is also disclosed.
  • Apparatus for automated regional temperature, pressure and liquid composition control in a body cavity is disclosed using cooling or heating, foam fractionation, and recirculation of a biological or biocompatible liquid to and from the body cavity.
  • a single double-barreled catheter is inserted into a body cavity.
  • Liquid is continuously withdrawn from the cavity by means of a first (outflow) pump connected to one barrel (lumen) of the catheter using sterile tubing.
  • liquid is continuously added to the cavity by means of a second (inflow) pump connected to the other barrel (lumen) of the catheter using sterile tubing.
  • the catheter incorporates a sensor located along its length (and thermally insulated from it) which is capable of sensing both the temperature and pressure of the interior of the cavity in the vicinity of the catheter shaft.
  • Liquid pumped out of the outflow barrel of the catheter by means of the outflow pump is conducted via the tubing to a conditioning chamber.
  • the liquid is conditioned by irradiation with short wave ultraviolet light to sterilize the liquid.
  • the liquid in the conditioning chamber is also continuously permeated by fine bubbles of gas from a pressurized gas source to entrain contaminants by foam fractionation and to remove them as foam.
  • Fresh liquid is preferably continuously added to the chamber for example by gravity feed from an external reservoir (eg. hanging bag), and the excess liquid is drained into a waste reservoir from an overflow aperture in the chamber. This overflow collects surface foam containing concentrated contaminants extracted by the foam fractionation effect of the bubbles.
  • the liquid in the conditioning chamber is cooled by means of refrigeration of the chamber walls or warmed by means of heating of the chamber walls.
  • the temperature of the chamber is measured by means of a temperature sensor in contact with a portion of the chamber, and feedback- controlled by means of closed loop feedback control of a chiller/heater unit.
  • Liquid is withdrawn from the chamber by means of the inflow pump and conducted to the inflow barrel of the catheter via sterile tubing where it is discharged into the body cavity.
  • a secondary catheter which drains liquid back to the chamber at a slower rate relative to the primary catheter may be positioned in a distant portion of the body cavity to improve distribution of the recirculated liquid.
  • the flow rates of the inflow and outflow pumps are preferably feedback-regulated based on intra-cavity temperature and pressure information relayed from the sensor in the primary catheter.
  • desired temperature and pressures can be achieved within the cavity.
  • Preprogrammed temperature and pressure profiles can be executed over several days by means of an automated computer-based system.
  • Flow in the secondary catheter, if present, is regulated based on information from a sensor capable of measuring the temperature of the liquid removed by this catheter. Greater flow through this catheter can improve the distribution of temperature-controlled liquid to an extremity of a body cavity.
  • Drugs or other agents may be added to the circulating liquid via the external reservoir.
  • Gaseous exchange between the bubbled gas and the liquid in the chamber can be used to oxygenate, adjust pH, or otherwise condition the liquid while contaminants are removed by foam fractionation and collected as waste.
  • Fig. 1 is a block diagram depicting the main components of a preferred embodiment of the device and their interconnections.
  • Fig. 2A is an illustration, at a larger scale, of the preferred embodiment of catheter tip (at the intracavity end) for the primary catheter.
  • Fig. 2B is a further view of the preferred catheter tip, showing a microsensor package mounted in a longitudinal groove.
  • Fig. 3A is a schematic depiction of a human body, showing some of the anatomical sites in which a catheter according to the invention can be positioned.
  • Fig. 3B depicts positioning of a primary catheter according to the invention in the C1-C2 subarachnoid space and the secondary catheter according to the invention in the lumbar cistern for spinal cord cooling.
  • Fig. 3C depicts positioning of a primary catheter according to the invention in the lateral ventricle of the brain and the secondary catheter according to the invention in the C1-C2 subarachnoid space for brainstem cooling.
  • Fig. 4 is a graphical representation of brain temperature and pressure data collected using one embodiment of the apparatus of the invention in an anesthetized pig. It illustrates three different runs as Figures 4A, 4B, and 4C.
  • Figure 1 shows a preferred embodiment in which a body liquid is circulated from a body cavity 35 to one or more conditioning chambers and is then returned to the body cavity. Withdrawal of the liquid and primary return is preferably done by a double-barrelled primary catheter 8, although two separate catheters, one for withdrawal of the liquid and one for its return are within the scope of the invention.
  • a secondary catheter 1 is also present to improve distribution of the recirculated liquid to a distal portion of the cavity.
  • the primary catheter 8 is preferably a cylindrical catheter made of biocompatible material that is divided internally into two lumens 18 and 19.
  • the insertion (also called distal") end 8A of the catheter has openings to each lumen located near its tip.
  • the catheter is fabricated from a biocompatible plastic and has a diameter of 5 mm.
  • each lumen is connected separately to tubing.
  • a sensor package 21 is incorporated into the wall of the catheter such that the sensor package 21 can measure the pressure and temperature of the surrounding tissues.
  • a sensor package 21 A can be separate from the catheter and inserted into the body cavity in a different location.
  • the pressure-sensitive portion of the sensor package is a miniature 4-wire strain gauge 171 containing a sealed 1 atm pressure reference and connected to an electronic data display and data storage external to the patient.
  • the temperature-sensing portion of the sensor package is a fine T-type thermocouple wire connected 172, 173 connected to electronic thermocouple display and data and storage external to the patient.
  • the data display and storage are shown schematically as monitor 142 and computer 141.
  • Wires 150 are shown as connecting sensor package 21 to the computer 141
  • wires 151 are shown as connecting sensor package 21A to the computer to transfer data from the strain gauge and the thermocouple.
  • the data can be relayed by wireless links, as indicated by antenna 142 on the computer, if preferred.
  • one end of an optional single-barreled secondary catheter 1 is inserted into a portion of the body cavity 35 distant from catheter 8, as at 36.
  • the other end of catheter 1 is connected via sterile tubing 101 to a burette 2.
  • the height "H" of the burette above the point of entry 36 regulates the pressure head opposing flow through this catheter.
  • the burette may be raised or lowered to adjust flow.
  • a sensor capable of measuring the temperature of the liquid withdrawn from catheter 1 is located at some point in the liquid pathway. Conveniently, this sensor is within the catheter, as shown at 102, but it could also be positioned within tubing 101.
  • the sensor 102 is connected by wires (not shown) or a wireless link (shown by antenna 103) to the computer 141.
  • the liquid is discharged from burette 2 into conditioning chamber 7 by tubing 130.
  • the conditioning chamber is preferably rectangular in shape with a number of internal baffles 104, 106, 108 which slow the passage of liquid through the chamber and promote mixing.
  • thermocouple 105 The temperature of liquid in the conditioning chamber is monitored by a thermocouple 105.
  • the temperature sensed is communicated to computer 141 by wireless communication (as shown diagrammatically by antenna 107, which communicates with antenna 142, or by wires (not shown).
  • the primary catheter 8 runs from an insertion tip 8A within the body to an external tip 8B.
  • Catheter 8 has two lumens, outflow barrel (lumen) 18 and inflow barrel 19 (lumen) (Fig 2A).
  • Outflow barrel 18 takes liquid from the body, passes it through sterile tubing 110, pump 5 sterile tubing 112 and into the conditioning chamber 7.
  • the liquid undergoes sterilization by means of an ultraviolet (UV) lamp 4, and foam fractionation by fine gas bubbles 6 discharged from block bubbler 13, which can for example be airstone or limewood.
  • UV ultraviolet
  • block bubbler 13 which can for example be airstone or limewood.
  • the high surface area of these fine bubbles promote the removal of amphipathic molecules such as proteinaceous contaminants by concentration of the contaminants in the overlying foam.
  • Gas is provided by gas cylinder 118, regulator 15 and gas addition line 120. Oxygenation and pH balancing can also occur depending on the gas and liquid used.
  • a mixture of 95% oxygen and 5% carbon dioxide gas can be used to both oxygenate the liquid and generate a physiologic pH by means of the interaction of bicarbonate in the liquid and carbon dioxide in the gas (a process known as bicarbonate buffering).
  • a low-oxygen environment or non-physiologic pH may be desired and can be accomplished by the appropriate selection of liquid and gas.
  • the flow rate of the gas may be adjusted to the minimum gas flow required to produce a substantial stream of fine bubbles (usually less than 1 l/min).
  • the overflow of concentrated foam and contaminants 160 is collected in partitioned area 3 of the chamber and conducted to a waste receptacle 124 through line 126.
  • Foam fractionation can be carried out by a variety of device configurations, all of which are intended to fall within the scope of the invention.
  • the liquid is bubbled by means of an airstone or limewood block and the contaminant-laden foam generated by the interaction of the stream of bubbles and dissolved contaminants in the liquid is separated from the liquid as it overflows into a waste container.
  • the foam can be directed into an elevated chimney arrangement in which the continual accumulation of foam due to the bubble stream causes it to overflow into a waste receptacle.
  • Another alternative is to separate the foam from the liquid by applying suction to the foam.
  • the foam itself may be generated by a number of means.
  • the foaming action can be made to occur by spraying the liquid at high velocity over a series of obstacles in a chamber, or by violent mixing of the liquid with the air or gas in a chamber using an impeller, or by drawing a mixture of liquid and gas into a Venturi tube.
  • Liquid leaving the chamber passes around the baffles into exit portion 17, and then passes through tubing 128 from portion 17 of the chamber through pump 16 and sterile tubing 130 to end 8B of catheter 8. It then passes through the inflow barrel 19 of the catheter 8 into the body cavity.
  • Continuous alimentation of the system with fresh biocompatible liquid from an elevated receptacle 9 is accomplished via passage of fresh liquid through a drip chamber 11 and tubing 132 connected to the chamber 7.
  • the preferred rate of alimentation with fresh liquid is 100-150 ml/h. For larger cavities with greater liquid absorption, such as the peritoneum, a faster rate may be required.
  • the addition of external liquid to the system provides a means of ensuring adequate liquid levels in the chamber 7, and also of adding drugs, modulating the composition of the recirculated liquid, diluting contaminants, and driving the overflow of contaminant-laden foam toward the waste receptacle 10.
  • Liquid flow direction through the chamber 7 is preferably reversible, thereby permitting the primary catheter pumps 5 and 16 to be reversed in the case of a blockage condition should one occur.
  • the saline or other biocompatible liquid can contain chemotherapeutic agents.
  • Cavities containing little or no endogenous liquids, such as the mediastinum of the chest, can simply be infused with saline or other biocompatible liquid, which can then recirculated to achieve the desired temperature and pressure over the desired time period.
  • Pressure and temperature are continuously monitored by means of sensors mounted on the primary catheter 8 as described with respect to sensor package 21.
  • the strain gauge sensor 171 is referenced against atmospheric pressure to measure intracavity pressure. It and the thermocouple are conveniently present as part of a sensor package 21 ( Figure 8B).
  • Other sensor technologies are available for the measurement of pressure and temperature, including the use of fiberoptic interferometry, and are intended to fall within the scope of the invention.
  • the readings from these sensors (and optional sensor 102) are displayed on monitor 142 and optionally are inputs to the computer 141 for automated process control.
  • computer 141 controls regulator 15, heater 14, ultraviolet sterilizer 4, and pumps 5 and 16 as shown diagrammatically by dashed control lines 190.
  • burette 2 and drip unit 11 can be replaced with automatic liquid supply regulating apparatus for automated control of liquid supply if desired.
  • the primary catheter 8 implies that a portion of the inflow liquid will be immediately drawn into the outflow port within the cavity. Nevertheless, a dispersion rate on the order of 50% of temperature-controlled liquid away from the catheter will occur, and the flow rate can be increased over a broad range without creating harmful pressure differentials.
  • the primary catheter can be replaced with two separate catheters, which replace barrels 18 and 19 respectively, located in close proximity to one another. This is not preferred, however, because the risk of injury and infection is increased when two catheters are implanted instead of one.
  • the optional secondary catheter 1 is preferably a single-lumen catheter which may be inserted in the body cavity 35 in a location 36 that is distant from the area of insertion of the primary catheter, to drain liquid into the conditioning chamber.
  • the purpose of this optional catheter is to draw liquid from the area of the body cavity near the primary catheter, where temperature control is easiest to maintain by pumps 5 and 16, toward an extremity of the cavity where temperature would otherwise be poorly controlled.
  • the primary catheter is positioned in the ventricles of the brain, for example, the secondary catheter can be positioned in the lumbar cistern (a CSF-containing space in the low back) to draw temperature-controlled liquid over the spinal cord.
  • the temperature of the liquid in the secondary catheter is measured by a sensor positioned either within the catheter itself (as in the preferred embodiment at
  • the flow through the secondary catheter may be regulated by means of a standard lumbar drain arrangement in which the liquid is conducted to a burette 11 positioned at a fixed height above the patient.
  • the height H of the placement of the burette determines the pressure head which must be overcome before the catheter drains. Drainage from the burette is then conducted back to the conditioning chamber by gravity.
  • the height of the drain kit may be lowered to increase the rate of flow through the secondary catheter until the desired temperature of the drained liquid, and, by inference, within the extremity of the body cavity, is achieved.
  • the secondary catheter can be drained by means of a pump 134 (shown in phantom) in line 132.
  • pump 134 is feedback- controlled based on the temperature of the drained liquid. It can also be controlled from the computer by control line 191.
  • Pumps 5 and 16 can be any suitable pumps for the pumping of sterile liquid.
  • the pumps are peristaltic tubing pumps driven by electric motors which can be controlled by computer 141.
  • Chamber 7 is cooled or heated to a desired temperature by means of heating and/ or cooling means 14.
  • means 14 is a solid state chiller/heater device which makes use of Peltier elements to cool or heat the walls of the chamber 7.
  • the particular heating and cooling means are not critical, and can be combined or separate. For example, units using compressor-based refrigeration and electric resistance heaters can be used. Depending on the use to which the apparatus is to be put, there can be only heating means, or only cooling means, or both heating and cooling means present.
  • Fig. 2A shows a close view of the insertion tip 8A of the primary catheter 8.
  • the lumen 18 removes liquid from the cavity, while the lumen 19 infuses liquid into the cavity.
  • Orifices 20 are cut into the tip and open from the lumens to the cavity.
  • Each of the lumens is D-shaped, so that the overall cross-section of the catheter 8 is cylindrical.
  • the diameter of the catheter shaft is preferably on the order of 5 mm for placement in the central nervous system, but may be larger for use in other body cavities.
  • Other catheter geometries with two lumens for conducting inflow and outflow, including coaxial lumens, and variations of the tip apertures are also intended to fall within the scope of the invention.
  • two separate catheters can be used instead of a double- barreled catheter.
  • Fig. 2B shows a view of the insertion tip 8A and a portion of the shaft of the primary catheter 8.
  • Sensor package 21 is positioned in a longitudinal groove in the shaft.
  • the sensor package 21 monitors pressure using a strain gauge device 171 and temperature using a thermocouple device 172.
  • the thermocouple sensor 173 is positioned away from the catheter wall such that it measures primarily the temperature of the environment outside the catheter but within the body cavity, rather than the temperature of the catheter wall.
  • the temperature within the cavity is a function of the overall flow rate between the inflow and outflow barrels of the primary catheter 8 within the cavity, the rate of heat removal or addition to the recirculating liquid by the chiller/heater 14, and the rate of perfusion of the cavity contents by blood.
  • the rate of pumping of liquid out of the cavity by the outflow pump 5 is feedback-regulated to minimize the size of the difference between the intracavity temperature and the chamber temperature.
  • Intracavity temperature itself is controlled by means of feedback to the outflow pump 5 rate and the rate of heating or cooling by the chiller/heater of the liquid in tank 7. Since the body cavities to which the invention will be applied are essentially closed systems, the overall flow rate can be set by fixing either the inflow rate or the outflow rate at a given value.
  • Intra-cavity pressure is a function of net liquid removed or added to the cavity. When inflow exceeds outflow, the pressure will rise. Conversely, when the inflow rate is less than the outflow, pressure will fall. Hence, in the presence of constant outflow, the inflow pump rate may be varied as part of feedback loop with intracavity pressure as the controlled variable and pump rate as the manipulated variable to produce the desired pressure within the cavity.
  • the disclosed invention allows for the automated measurement of compliance within a body cavity.
  • Compliance is the change in pressure per unit of volume added to a cavity's contents, often expressed as the inverse of this ratio in units of ml/mmHg. In the intracranium, for example, normal compliance values are in the range 0.5-1.4 ml/mmHg. Compliance falls when organ swelling in response to injury occurs. Both high intracranial pressure and low compliance predict adverse outcome, but critical compliance changes tend to precede critical intracranial pressure changes, making compliance the preferred means of monitoring brain swelling.
  • the disclosed invention can monitor compliance by periodically stopping both inflow and outflow, then delivering a known volume of liquid into the ventricle (running the inflow pump in the forward direction or the outflow pump in the reverse direction for a defined time at a defined rate) and recording the pressure response.
  • Periodic compliance monitoring using reversed flow from the outflow pump has the additional benefit of periodically clearing the outflow port of the primary catheter of debris that may be drawn into this port by suction.
  • Compliance monitoring is incorporated into the preferred embodiment of the invention as a means of monitoring effects on organs within a body cavity during rewarming, as some organs, such as the brain, are known to respond to rewarming with swelling due to reactive hyperemia. Decreased compliance during the rewarming process is used as a signal to slow or temporarily reverse the rate of rewarming.
  • FIG. 3 shows schematic anatomical diagrams of human head and torso in lateral transparent view depicting a variety of possible catheter placement sites for the primary catheter insertion tip 8A.
  • Figure 3A shows suitable placements in the peritoneum 28, the pleural space 27, and in the ventricular system (lateral ventricle preferred) of the brain 26.
  • These are three important cavities in which continuous recirculation of a liquid at controlled temperatures and pressures with removal of contaminants and/or addition of drugs could be therapeutically useful.
  • a solution of chemotherapy agents for example, could be recirculated at these locations at a temperature higher than body temperature for the treatment of cancer.
  • Catheter access usually for the placement of passive drainage catheters
  • Another cavity amenable to catheterization for this purpose is the mediastinum (not visible in Figure 3).
  • the catheter can also be placed in other body cavities where heating or cooling, or removal of contaminants or insertion of drugs is desirable.
  • Figure 3B shows placement suitable for spinal cord injury.
  • the insertion tip 8A of primary catheter 8 is depicted in the subarachnoid space at 29 C1-C2 (cervical vertebrae one and two, while the secondary drainage catheter 8 is located in the lumbar cistern 30.
  • An artificial cerebrospinal solution at low temperature, for example, could be recirculated in these locations for hypothermic therapy in the case of spinal cord injury.
  • Fig. 3C depicts an arrangement in which the insertion tip 8A of the primary catheter 8 is inserted into one of the lateral ventricles at 31 , while the secondary catheter 8 is inserted in the C1-C2 subarachnoid space at 32. This arrangement is intended to promote optimal temperature modulation in the distal brainstem and cerebellum by means of recirculated artificial cerebrospinal solution, for example, at low temperature.
  • automated control of the system is achieved by means of computer 141 running a program of feedback loops based on sensor inputs and control outputs.
  • computer 141 provides the interface with the user and can download programmed instructions to the hardware via digital-to- analog/analog-to-digital (DAC/ADC) conversion as shown schematically at 190, 191.
  • DAC/ADC digital-to- analog/analog-to-digital
  • Inputs to the control system include: the temperature and pressure in the body cavity (from sensors 171 and 173), the temperature of the liquid emerging from the secondary catheter (if present), from sensor 102, the temperature of the conditioning chamber (from thermocouple 105), the status of the chiller/heater unit 14, and the status of battery backup power supply (not shown, but preferred to be present).
  • Outputs from the computer-based control system include: on/off, rate and pumping direction of the pumps 5 and 16 for the primary catheter, on/off, rate and pumping direction of the pump 13 for the secondary catheter (if present), and heat/cool and power level of the heating/cooling elements 14.
  • Chiller/heater drive vs. intracavity temperature In the preferred embodiment, the temperature of the liquid in the conditioning chamber is measured by means of a thermocouple sensor 105 in contact with the chamber. The temperature of the intracavity temperature as sensed at the primary catheter by thermocouple 173 serves as the controlled variable, while the cooling/heating activity of the chiller/heater 14 is the manipulated variable.
  • Outflow vs. intracavity-chamber temperature differential Sufficient circulation of liquid between the conditioning chamber 7 and the cavity 35 is achieved when the temperatures at these two locations approach one another closely. Outflow from the primary catheter through barrel 18 is adjusted based on the difference in temperature between the cavity 35 and the chamber 7 such that flow is increased until this difference reaches a preset minimum.
  • the controlled variable is the intracavity-chamber temperature difference
  • the manipulated variable is the rate of the outflow pump 5.
  • Inflow vs. Pressure Inflow from the primary catheter through barrel 19 is increased if the intra-cavity pressure is below the desired value and decreased if it is above the desired value.
  • the controlled variable is intracavity pressure measured by strain gauge 171
  • the manipulated variable is the rate of pump 16.
  • An equivalent arrangement may obtained by reversing the roles of the pumps.
  • a number of functionally equivalent schemes for the simultaneous control of temperature and pressure using the concept of bias flow or deltaflow (the difference between inflow and outflow rates) will be evident to one skilled in the art and are intended to be within the scope of the invention.
  • Outflow of the secondary catheter 1 vs. temperature of liquid emerging from the secondary catheter Outflow from the optional secondary catheter is adjusted based on the temperature of the liquid as measured by sensor 102 at some point within the outflow pathway. The flow rate is increased until the temperature comes to within a desired range of the temperature at the primary catheter to ensure adequate distribution of liquid to the extremity of cavity in the region of the secondary catheter.
  • the liquid temperature is measured within the secondary catheter at 102, and the flow rate is manually controlled by raising or lowering a gravity-based drain kit 2.
  • An automated version of this control loop is disclosed in which the flow rate through the secondary catheter is controlled by means of a pump 132. In the automated version, drain kit 2 is removed.
  • the automated system can execute a defined sequence of temperature and pressure manipulations over long periods (hours to days) according to preset or user-defined temperature and pressure profiles.
  • a number of safety features can be incorporated into the preferred embodiment of the automated system of the invention.
  • power to the system is backed up by means of an uninterruptible power supply (not shown) which can maintain the operation of critical systems in the event of temporary disconnection from or failure of the mains supply.
  • control of the pumps can preferably be switched to manual operation.
  • control software preferably includes a blockage detection routine that monitors the cavity pressure for loss of pressure control (intracavity pressure outside preset limits) and tests the catheters individually by measuring the pressure response to small volumes of liquid removed or added to the cavity. If the expected changes in pressure do not occur (rise in pressure in response to liquid added or a fall in pressure in response to liquid removed), then a blockage condition at the catheter is diagnosed.
  • Four blockage conditions may occur: blockage of the outflow lumen in the OUT direction, blockage of the outflow lumen in the IN direction, blockage of the inflow lumen in the OUT direction, and blockage of the inflow lumen in the IN direction. These conditions preferably trigger a clearance routine in which flow is temporarily reversed in the affected catheter to clear debris.
  • Total blockage in both the IN and OUT direction of a lumen that fails to clear is a non- recoverable condition that triggers an alarm signaling the need for operator intervention.
  • Pump motor failure or blockage of either inflow in both lumens or outflow in both lumens is also non-recoverable. Blockage of outflow in one lumen and/or inflow in the other, however, is recoverable by reversal of flow through the two lumens.
  • equipment and control systems can be twinned for further safety.
  • two computerized control systems can be operated so that the failure of one can be compensated by the other, and or two chillers can be operated in parallel.
  • Electrical contact circuits can also be used to monitor the connection status of the different parts of the system.
  • FIG. 1 An arrangement as shown in Figure 1 was used to remove cerebrospinal fluid and return a mixture of cerebrospinal fluid and artificial cerebrospinal fluid cooled to approximately 2°C in an adolescent pig (40 lbs). The animal was intubated and monitored under general anaesthesia. Rectal body temperature was controlled at 37°C using a heating pad. The primary catheter was inserted into the right lateral ventricle while a temperature probe was inserted into the brain parenchyma on the opposite side of the brain (left parietooccipital region). The indicated flow rates were produced by varying the speed of the outflow pump 5 and intracranial pressure was adjusted by controlling the speed of the inflow pump 8.

Abstract

Biocompatible liquid is pumped into a body cavity (35) (eg. subarachnoid space, peritoneum, mediastinum, pleural space) by means of one pump (16) and removed from it by means a second pump (5), preferably via a double-barreled catheter (8) is used for insertion and removal of the liquid. An optional secondary catheter (1) removes liquid from a distal area of the body cavity. Temperature and pressure are sensed within the cavity and can be controlled by adjusting liquid flow rates. While outside the body, the liquid can be ultraviolet-sterilized, foam fractionated to remove contaminants, oxygenated and pH balanced, cooled or warmed, and augmented with exogenous liquid that may contain drugs.

Description

DEVICE FOR THE EXTRAVASCULAR RECIRCULATION OF LIQUID IN BODY CAVITIES
Field of Invention
This invention relates to processes and devices for automated extracorporeal recirculation and chemical manipulation of biological and biocompatible liquids such as for example cerebrospinal fluid, artificial cerebrospinal fluid, saline, and Ringer's lactate in body cavities for the purposes of prevention or treatment of a variety of disorders.
Background of the Invention
A number of clinical situations exist in medicine in which automated control of the temperature, pressure and chemistry of liquid within a body cavity are likely to be therapeutically useful. These include:
1. Traumatic or ischemic brain and spinal cord injuries, in which temperatures below normal and control of pressure may improve outcome.
2. Hemorrhage in the regions of the brain and spinal cord, in which removal of blood may improve outcome.
3. Infection in the regions of the brain and spinal cord, in which addition of antibiotics or antivirals to the CSF spaces may be beneficial. Hypothermia, hyperthermia, or oscillation between hypothermia and hyperthermia, pressure control, and removal of infectious organisms
(pus) and inflammatory mediators from the cerebrospinal fluid (CSF) may also be beneficial. 4. Brain edema related to liver failure, in which hypothermia has been shown to be beneficial.
5. Malignancy in the regions of the brain and spinal cord, in which hyperthermia has been shown to increase the efficacy of chemotherapy and radiation in the treatment of glioblastoma multiforme, the most common, and usually fatal, form of brain cancer.
6. Infection in the region of other body cavities, including peritonitis, pleuritis, and mediastinitis, in which the continuous delivery of antibiotic, antiviral, or related therapies under controlled temperature and pressure could be useful. Such therapies have been delivered into the peritoneum and other cavities, but without feedback control of temperature or pressure.
7. Malignancy in the region of body cavities, including the peritoneum, pelvis, mediastinum, and pleural space, in which hyperthermia and/or the local delivery of chemotherapeutic agents have shown greater effectiveness than conventional therapies in some studies.
8. Ischemia of the intestine or colon, in which hypothermia might protect the tissues from ischemic damage. Such protection may apply in other organs subject to ischemia, such as the heart.
9. Surgery involving any of the above regions, in which local hypothermia can decrease the metabolic demands of tissues, resulting in decreased susceptibility to injury and decreased bleeding due to lower blood flow, and post-operative adverse events in such regions. Hypothermia in Brain and Spinal Cord Injuries
The protective effects of hypothermia applied during injuries has been extensively documented, and is currently in use intraoperatively in certain forms of brain surgery and cardiac surgery.
Hypothermia has been shown to be effective when applied contemporaneously with the injury in both brain trauma and brain ischemia in animals in a large number of studies. Disappointing early results with delayed hypothermia, and the resultant widespread notion of a narrow 'therapeutic window' dampened enthusiasm in this area for many years. Recent reports suggest that much longer hypothermic times than were previously contemplated can compensate for delays in treatment and produce outcomes comparable to contemporaneous hypothermia.
However, some studies indicate that the systemic complications of prolonged whole-body hypothermia (also called whole body cooling, or WBC) are a major barrier to the effectiveness of this therapy in either stroke or trauma in humans. As a result, some investigators have focused on a human strategy of selective brain cooling (also called SBC). Unfortunately, SBC is very difficult to achieve in large animals such as humans. Compared with smaller animals, the human head has a low surface area-to-volume ratio and a high degree of thermal inertia. The human brain is insulated from the surface of the head by approximately 2.5 cm of highly vascular scalp, bone, meninges and cerebrospinal fluid (CSF). In addition, the brain receives constant thermal input in the form of 20% of the cardiac output, or 1 L/min of blood at 37°C. Because of this, reduction of the surface temperature of the human head has been shown to be ineffective as a method of SBC.
An alternative to surface cooling is intra-arterial cooling using either bypass- cooled blood or intra-arterial cooling probes. Intra-arterial approaches suffer from the major inherent risk of endovascular instrumentation of the cranial arteries; that of precipitating stroke. To minimize this risk, such instrumentation is normally done under full dose heparin anticoagulation, which may be contraindicated in both trauma and stroke due to the risk of bleeding.
It has been taught to withdraw cerebrospinal fluid (CSF), cool it, and return the cooled CSF to a patient.
US Patent no. 4,904,237 (Janese, 1990) discloses a CSF exchange system which removes CSF from the lumbar cistern, filters out blood contaminants, cools, pH adjusts and performs diagnostic measurements, then returns the
CSF to the lumbar cistern by reversal of flow using a single reciprocating pump. This system seems intended primarily for the removal of subarachnoid blood from the CSF in the context of subarachnoid hemorrhage. In the preferred embodiment, 10 ml of CSF are exchanged in 25 s cycles, giving a flow rate of 24 ml/min. If the temperature of the returned CSF is at 4°C, this flow rate may not be adequate to achieve significant cooling in the spinal cord, where published flows of approximately 30 ml/min were required in a human trial (Davison e al., 1994).
US patent no. 6,379,331 (Barbut, 2002) discloses another medical device for intrathecal cooling of the spinal cord in which separate inflow and outflow catheters are inserted into the CSF spaces of the spinal cord such that their tips are at the extremities of the cavity to be cooled. CSF is extracted from one catheter, cooled, and returned to the second catheter by means of a single pump without automated feedback control. The flow rate of the single pump is adjusted to keep intraspinal pressure (as estimated from the pressure of the extracorporeal fluid, and not from measurement within the cavity) below a safe level. This system is intended primarily for the special case of intraoperative spinal cord cooling in the context of abdominal aortic aneurysm surgery and provides no means of continued cooling over 24 h or more, as required for delayed hypothermia to be effective. Alternate placement of one of the catheters into the lateral ventricle of the brain is disclosed as a method of cooling the brain, although practical brain cooling would seem unlikely due to flow rate limitations. A difficulty with any catheter arrangement in which the catheter tips are separated in space is that pressure differentials may occur between the inflow and outflow regions at higher flow rates. Hence, the maximal flow is limited by the maximal safe pressure in the region of the inflow catheter, where pressure is high, and minimal safe pressure in the region of the outflow catheter, where pressure is low. Placement of two catheters in the brain ventriclular system such that their tips are relatively close together suffers from the disadvantage of having to pierce the brain twice, doubling the risk of intraparenchymal hemorrhage due to catheter placement.
US patent no. 4,445,500 (Osterholm) discloses a treatment for stroke involving the recirculation of an oxygenated perfluorocarbon emulsion in the subarachnoid (CSF) space. This system is intended to counteract ischemic injuries of the central nervous system by providing sufficient oxygen in the perfusate to allow continued tissue metabolism in the face of insufficient blood flow. The system depends on an involved process for the manufacture and maintenance of the perfluorocarbon emulsion, which is a fluid whose biocompatibility would need to be established. As in the previously discussed patent, a single pump is again used for circulation of the fluid within the subarachnoid space, which precludes active pressure modulation, and the inflow and outflow catheters are separated. The low flow rates possible under this configuration (<60 ml/min) are disclosed as sufficient for adequate brain oxygentation with the emulsion used. Intracranial pressure measurements are made by means of a double lumen catheter in which one lumen is devoted to pressure measurements. The infusion rate into the brain is adjusted manually to keep the pressure below a safe limit. The temperature of the emulsion may be adjusted extracorporeally, but no measurements of temperature are made within the CNS. Together with the low flow rates, this would seem to preclude practical and precise therapeutic temperature modulation. Precise control of temperature is required in hypothermic therapy, particularly during the dangerous rewarming stage, and to an even greater extent in therapeutic hyperthermia, in which overheating can severely damage normal tissue. Finally, with regard to the removal of contaminants, the Osterholm system calls for microfiltration of the emulsion as a means of removing bacteria, but discloses no means of removal of other contaminants, such as proteins or blood products.
Liquid in non-CNS body cavities
Devices for recirculation of liquids in the peritoneal cavity have been disclosed in, for example, US patent no. 6254567, 6409699, and 5141493. These devices are dialysate circulators for the purpose of continuous flow-through intraperitoneal dialysis (CFPD) used in the treatment of kidney or liver failure. Many of these designs incorporate a heater whose purpose is to warm the dialysate to body temperature before it enters the body, but therapeutic temperature modulation is not encompassed. They generally feature a means of maintaining constant pressure of the dialysate fluid extracorporeally, but do not accomplish pressure modulation within the cavity by use of independent inflow and outflow pumps. These devices are also not intended for the delivery of drugs or the removal of contaminants such as blood or pus.
Foam Fractionation
Foam fractionation is a technique for the removal of proteins and other contaminants from a liquid. This technique is used in marine aquaculture, where it is commonly known as 'protein skimming'. Dissolved amphipathic (partly water soluble and partly non-water soluble) molecules such as proteins tend to accumulate at an air/water interface since part of the molecule is more stable when dissolved in aqueous solution and part is more stable in air. Such molecules can be removed with high efficiency from liquids with favorable physical properties by saturation of the solution with fine bubbles. The bubbles accumulate proteins at the air/water interface and the resulting foam rises to the top of the liquid, where it may be collected or skimmed off. As an additional benefit, the intimate contact of air or of a gas mixture containing oxygen can oxygenate the liquid. Contact of an oxygen-carbon dioxide gas mixture with a bicarbonate-buffered solution, for example, can both oxygenate and pH balance the solution. US patents no. 6436295, 5562821 , 5554280, 5122267, 5665227, and 5380160, for example, describe devices for foam fractionation in marine aquariums. Foam fractionation is also used in the purification of proteins and drugs in the pharmaceutical industry. Foam fractionation has apparently not been disclosed for use in the purification of a bulk liquid for recirculation within a body cavity.
Summary of the Invention A process and device are disclosed for liquid recirculation to and from a body cavity (eg. subarachnoid space, cerebral ventricular system, mediastinum, pleural space, peritoneum). Preferably a two channel catheter is used where one channel inserts liquid and the other removes it. One or more secondary drainage catheters may also be inserted as needed to enhance the distribution of the liquid within the cavity. In a preferred embodiment equipped with automated feedback-controlled pumps and heating/cooling elements, the device allows control of the temperature and pressure of the liquid over short or long time periods (hours to days) according to predetermined protocols. Further preferred embodiments permit manipulation of the liquid, such as dilution with artificial liquids, removal of contaminants by foam fractionation, oxygenation, pH balancing, and addition of chemical agents or drugs.
A process and device for removal of body liquids, treatment of them by foam fractionation and optional other processes, and their return to the body cavity from which they came is also disclosed.
Apparatus for automated regional temperature, pressure and liquid composition control in a body cavity is disclosed using cooling or heating, foam fractionation, and recirculation of a biological or biocompatible liquid to and from the body cavity.
In the preferred embodiment, a single double-barreled catheter is inserted into a body cavity. Liquid is continuously withdrawn from the cavity by means of a first (outflow) pump connected to one barrel (lumen) of the catheter using sterile tubing. At the same time, liquid is continuously added to the cavity by means of a second (inflow) pump connected to the other barrel (lumen) of the catheter using sterile tubing. The catheter incorporates a sensor located along its length (and thermally insulated from it) which is capable of sensing both the temperature and pressure of the interior of the cavity in the vicinity of the catheter shaft.
Liquid pumped out of the outflow barrel of the catheter by means of the outflow pump is conducted via the tubing to a conditioning chamber. Preferably, the liquid is conditioned by irradiation with short wave ultraviolet light to sterilize the liquid. Preferably also, the liquid in the conditioning chamber is also continuously permeated by fine bubbles of gas from a pressurized gas source to entrain contaminants by foam fractionation and to remove them as foam. Fresh liquid is preferably continuously added to the chamber for example by gravity feed from an external reservoir (eg. hanging bag), and the excess liquid is drained into a waste reservoir from an overflow aperture in the chamber. This overflow collects surface foam containing concentrated contaminants extracted by the foam fractionation effect of the bubbles. At the same time, the liquid in the conditioning chamber is cooled by means of refrigeration of the chamber walls or warmed by means of heating of the chamber walls. The temperature of the chamber is measured by means of a temperature sensor in contact with a portion of the chamber, and feedback- controlled by means of closed loop feedback control of a chiller/heater unit. Liquid is withdrawn from the chamber by means of the inflow pump and conducted to the inflow barrel of the catheter via sterile tubing where it is discharged into the body cavity.
A secondary catheter which drains liquid back to the chamber at a slower rate relative to the primary catheter may be positioned in a distant portion of the body cavity to improve distribution of the recirculated liquid.
At the primary catheter, the flow rates of the inflow and outflow pumps are preferably feedback-regulated based on intra-cavity temperature and pressure information relayed from the sensor in the primary catheter. By appropriate regulation of the inflow and outflow rates, desired temperature and pressures can be achieved within the cavity. Preprogrammed temperature and pressure profiles can be executed over several days by means of an automated computer-based system. Flow in the secondary catheter, if present, is regulated based on information from a sensor capable of measuring the temperature of the liquid removed by this catheter. Greater flow through this catheter can improve the distribution of temperature-controlled liquid to an extremity of a body cavity.
Drugs or other agents may be added to the circulating liquid via the external reservoir. Gaseous exchange between the bubbled gas and the liquid in the chamber can be used to oxygenate, adjust pH, or otherwise condition the liquid while contaminants are removed by foam fractionation and collected as waste.
Brief Description of the Drawings
The invention will be further described by reference to the drawings, in which
Fig. 1 is a block diagram depicting the main components of a preferred embodiment of the device and their interconnections. Fig. 2A is an illustration, at a larger scale, of the preferred embodiment of catheter tip (at the intracavity end) for the primary catheter.
Fig. 2B is a further view of the preferred catheter tip, showing a microsensor package mounted in a longitudinal groove.
Fig. 3A is a schematic depiction of a human body, showing some of the anatomical sites in which a catheter according to the invention can be positioned.
Fig. 3B depicts positioning of a primary catheter according to the invention in the C1-C2 subarachnoid space and the secondary catheter according to the invention in the lumbar cistern for spinal cord cooling.
Fig. 3C depicts positioning of a primary catheter according to the invention in the lateral ventricle of the brain and the secondary catheter according to the invention in the C1-C2 subarachnoid space for brainstem cooling. Fig. 4 is a graphical representation of brain temperature and pressure data collected using one embodiment of the apparatus of the invention in an anesthetized pig. It illustrates three different runs as Figures 4A, 4B, and 4C.
Detailed Description of the Invention and Preferred Embodiments
Figure 1 shows a preferred embodiment in which a body liquid is circulated from a body cavity 35 to one or more conditioning chambers and is then returned to the body cavity. Withdrawal of the liquid and primary return is preferably done by a double-barrelled primary catheter 8, although two separate catheters, one for withdrawal of the liquid and one for its return are within the scope of the invention. Optionally, a secondary catheter 1 is also present to improve distribution of the recirculated liquid to a distal portion of the cavity. The primary catheter 8 is preferably a cylindrical catheter made of biocompatible material that is divided internally into two lumens 18 and 19. The insertion (also called distal") end 8A of the catheter has openings to each lumen located near its tip. In the preferred embodiment, the catheter is fabricated from a biocompatible plastic and has a diameter of 5 mm. At the external end (also called the "proximal" end") 8B of the catheter, each lumen is connected separately to tubing. In one embodiment, a sensor package 21 is incorporated into the wall of the catheter such that the sensor package 21 can measure the pressure and temperature of the surrounding tissues. In another embodiment, a sensor package 21 A can be separate from the catheter and inserted into the body cavity in a different location. In the preferred embodiment, the pressure-sensitive portion of the sensor package is a miniature 4-wire strain gauge 171 containing a sealed 1 atm pressure reference and connected to an electronic data display and data storage external to the patient. In the preferred embodiment, the temperature-sensing portion of the sensor package is a fine T-type thermocouple wire connected 172, 173 connected to electronic thermocouple display and data and storage external to the patient. The data display and storage are shown schematically as monitor 142 and computer 141. Wires 150 are shown as connecting sensor package 21 to the computer 141 , and wires 151 are shown as connecting sensor package 21A to the computer to transfer data from the strain gauge and the thermocouple. However, the data can be relayed by wireless links, as indicated by antenna 142 on the computer, if preferred.
In the preferred embodiment, one end of an optional single-barreled secondary catheter 1 is inserted into a portion of the body cavity 35 distant from catheter 8, as at 36. The other end of catheter 1 is connected via sterile tubing 101 to a burette 2. The height "H" of the burette above the point of entry 36 regulates the pressure head opposing flow through this catheter. The burette may be raised or lowered to adjust flow. Preferably, a sensor capable of measuring the temperature of the liquid withdrawn from catheter 1 is located at some point in the liquid pathway. Conveniently, this sensor is within the catheter, as shown at 102, but it could also be positioned within tubing 101.
The sensor 102 is connected by wires (not shown) or a wireless link (shown by antenna 103) to the computer 141. The liquid is discharged from burette 2 into conditioning chamber 7 by tubing 130. The conditioning chamber is preferably rectangular in shape with a number of internal baffles 104, 106, 108 which slow the passage of liquid through the chamber and promote mixing.
The temperature of liquid in the conditioning chamber is monitored by a thermocouple 105. The temperature sensed is communicated to computer 141 by wireless communication (as shown diagrammatically by antenna 107, which communicates with antenna 142, or by wires (not shown).
The primary catheter 8 runs from an insertion tip 8A within the body to an external tip 8B. Catheter 8 has two lumens, outflow barrel (lumen) 18 and inflow barrel 19 (lumen) (Fig 2A). Outflow barrel 18 takes liquid from the body, passes it through sterile tubing 110, pump 5 sterile tubing 112 and into the conditioning chamber 7. In the conditioning chamber 7, the liquid undergoes sterilization by means of an ultraviolet (UV) lamp 4, and foam fractionation by fine gas bubbles 6 discharged from block bubbler 13, which can for example be airstone or limewood. The high surface area of these fine bubbles promote the removal of amphipathic molecules such as proteinaceous contaminants by concentration of the contaminants in the overlying foam. Gas is provided by gas cylinder 118, regulator 15 and gas addition line 120. Oxygenation and pH balancing can also occur depending on the gas and liquid used. When using an artificial CSF containing a 10 mM concentration of bicarbonate, for example, a mixture of 95% oxygen and 5% carbon dioxide gas can be used to both oxygenate the liquid and generate a physiologic pH by means of the interaction of bicarbonate in the liquid and carbon dioxide in the gas (a process known as bicarbonate buffering). In the treatment of a malignant disorder, a low-oxygen environment or non-physiologic pH may be desired and can be accomplished by the appropriate selection of liquid and gas. The flow rate of the gas may be adjusted to the minimum gas flow required to produce a substantial stream of fine bubbles (usually less than 1 l/min). The overflow of concentrated foam and contaminants 160 is collected in partitioned area 3 of the chamber and conducted to a waste receptacle 124 through line 126.
Foam fractionation can be carried out by a variety of device configurations, all of which are intended to fall within the scope of the invention. In the preferred configuration the liquid is bubbled by means of an airstone or limewood block and the contaminant-laden foam generated by the interaction of the stream of bubbles and dissolved contaminants in the liquid is separated from the liquid as it overflows into a waste container. Alternatively, the foam can be directed into an elevated chimney arrangement in which the continual accumulation of foam due to the bubble stream causes it to overflow into a waste receptacle.
Another alternative is to separate the foam from the liquid by applying suction to the foam. The foam itself may be generated by a number of means. The foaming action can be made to occur by spraying the liquid at high velocity over a series of obstacles in a chamber, or by violent mixing of the liquid with the air or gas in a chamber using an impeller, or by drawing a mixture of liquid and gas into a Venturi tube.
Liquid leaving the chamber passes around the baffles into exit portion 17, and then passes through tubing 128 from portion 17 of the chamber through pump 16 and sterile tubing 130 to end 8B of catheter 8. It then passes through the inflow barrel 19 of the catheter 8 into the body cavity. Continuous alimentation of the system with fresh biocompatible liquid from an elevated receptacle 9 is accomplished via passage of fresh liquid through a drip chamber 11 and tubing 132 connected to the chamber 7. The preferred rate of alimentation with fresh liquid is 100-150 ml/h. For larger cavities with greater liquid absorption, such as the peritoneum, a faster rate may be required. The addition of external liquid to the system provides a means of ensuring adequate liquid levels in the chamber 7, and also of adding drugs, modulating the composition of the recirculated liquid, diluting contaminants, and driving the overflow of contaminant-laden foam toward the waste receptacle 10. Liquid flow direction through the chamber 7 is preferably reversible, thereby permitting the primary catheter pumps 5 and 16 to be reversed in the case of a blockage condition should one occur.
Many different liquids can be used with the apparatus of the invention. In the case of body cavities which already contain substantial quantities of a naturally occurring liquid, such as the cerebrospinal fluid of the central nervous system, this naturally occurring liquid can be drawn out of the cavity and mixed with a quantity of artificially manufactured cerebrospinal fluid substitute. The mixture of the naturally occurring liquid and the artificial substitute is then recirculated within the cavities containing the brain and spinal cord to achieve the desired temperatures and pressures within the cavity. A variety of such artificial cerebrospinal fluids and the means to manufacture them are well known in the scientific literature. As another example, the peritoneal fluid which occurs naturally in the peritoneal cavity of the abdomen can be drawn from that cavity and mixed with artificial saline. This mixture is then recirculated within the cavity. In the case of treatment of a malignancy, the saline or other biocompatible liquid can contain chemotherapeutic agents. Cavities containing little or no endogenous liquids, such as the mediastinum of the chest, can simply be infused with saline or other biocompatible liquid, which can then recirculated to achieve the desired temperature and pressure over the desired time period.
Pressure and temperature are continuously monitored by means of sensors mounted on the primary catheter 8 as described with respect to sensor package 21. In the preferred embodiment, the strain gauge sensor 171 is referenced against atmospheric pressure to measure intracavity pressure. It and the thermocouple are conveniently present as part of a sensor package 21 (Figure 8B). Other sensor technologies are available for the measurement of pressure and temperature, including the use of fiberoptic interferometry, and are intended to fall within the scope of the invention. The readings from these sensors (and optional sensor 102) are displayed on monitor 142 and optionally are inputs to the computer 141 for automated process control. In an automated control embodiment, computer 141 controls regulator 15, heater 14, ultraviolet sterilizer 4, and pumps 5 and 16 as shown diagrammatically by dashed control lines 190. Optionally, burette 2 and drip unit 11 can be replaced with automatic liquid supply regulating apparatus for automated control of liquid supply if desired.
The close proximity of the inflow and outflow ports at the tip of 8A the primary catheter 8 implies that a portion of the inflow liquid will be immediately drawn into the outflow port within the cavity. Nevertheless, a dispersion rate on the order of 50% of temperature-controlled liquid away from the catheter will occur, and the flow rate can be increased over a broad range without creating harmful pressure differentials. If desired, the primary catheter can be replaced with two separate catheters, which replace barrels 18 and 19 respectively, located in close proximity to one another. This is not preferred, however, because the risk of injury and infection is increased when two catheters are implanted instead of one.
The optional secondary catheter 1 is preferably a single-lumen catheter which may be inserted in the body cavity 35 in a location 36 that is distant from the area of insertion of the primary catheter, to drain liquid into the conditioning chamber. The purpose of this optional catheter is to draw liquid from the area of the body cavity near the primary catheter, where temperature control is easiest to maintain by pumps 5 and 16, toward an extremity of the cavity where temperature would otherwise be poorly controlled. If the primary catheter is positioned in the ventricles of the brain, for example, the secondary catheter can be positioned in the lumbar cistern (a CSF-containing space in the low back) to draw temperature-controlled liquid over the spinal cord. The temperature of the liquid in the secondary catheter is measured by a sensor positioned either within the catheter itself (as in the preferred embodiment at
102), or at another point such as the point at which the liquid is discharged into the chamber.
The flow through the secondary catheter may be regulated by means of a standard lumbar drain arrangement in which the liquid is conducted to a burette 11 positioned at a fixed height above the patient. The height H of the placement of the burette determines the pressure head which must be overcome before the catheter drains. Drainage from the burette is then conducted back to the conditioning chamber by gravity. In this arrangement, given a positive pressure within the body cavity, the height of the drain kit may be lowered to increase the rate of flow through the secondary catheter until the desired temperature of the drained liquid, and, by inference, within the extremity of the body cavity, is achieved. In another embodiment of the invention, the secondary catheter can be drained by means of a pump 134 (shown in phantom) in line 132. In this embodiment pump 134 is feedback- controlled based on the temperature of the drained liquid. It can also be controlled from the computer by control line 191.
Pumps 5 and 16 (and 134 if present) can be any suitable pumps for the pumping of sterile liquid. In the preferred embodiment, the pumps are peristaltic tubing pumps driven by electric motors which can be controlled by computer 141.
Chamber 7 is cooled or heated to a desired temperature by means of heating and/ or cooling means 14. In the preferred embodiment, means 14 is a solid state chiller/heater device which makes use of Peltier elements to cool or heat the walls of the chamber 7. However, the particular heating and cooling means are not critical, and can be combined or separate. For example, units using compressor-based refrigeration and electric resistance heaters can be used. Depending on the use to which the apparatus is to be put, there can be only heating means, or only cooling means, or both heating and cooling means present.
Fig. 2A shows a close view of the insertion tip 8A of the primary catheter 8. The lumen 18 removes liquid from the cavity, while the lumen 19 infuses liquid into the cavity. Orifices 20 are cut into the tip and open from the lumens to the cavity. Each of the lumens is D-shaped, so that the overall cross-section of the catheter 8 is cylindrical. The diameter of the catheter shaft is preferably on the order of 5 mm for placement in the central nervous system, but may be larger for use in other body cavities. Other catheter geometries with two lumens for conducting inflow and outflow, including coaxial lumens, and variations of the tip apertures are also intended to fall within the scope of the invention. Optionally, two separate catheters can be used instead of a double- barreled catheter.
Fig. 2B shows a view of the insertion tip 8A and a portion of the shaft of the primary catheter 8. Sensor package 21 is positioned in a longitudinal groove in the shaft. The sensor package 21 monitors pressure using a strain gauge device 171 and temperature using a thermocouple device 172. The thermocouple sensor 173 is positioned away from the catheter wall such that it measures primarily the temperature of the environment outside the catheter but within the body cavity, rather than the temperature of the catheter wall.
Control of Temperature and Pressure
The temperature within the cavity is a function of the overall flow rate between the inflow and outflow barrels of the primary catheter 8 within the cavity, the rate of heat removal or addition to the recirculating liquid by the chiller/heater 14, and the rate of perfusion of the cavity contents by blood. In general, the greater the flow through the primary catheter, the more closely will the intra- cavity temperature approach that of the liquid in the conditioning chamber. In the preferred embodiment of the invention, the rate of pumping of liquid out of the cavity by the outflow pump 5 is feedback-regulated to minimize the size of the difference between the intracavity temperature and the chamber temperature. Intracavity temperature itself is controlled by means of feedback to the outflow pump 5 rate and the rate of heating or cooling by the chiller/heater of the liquid in tank 7. Since the body cavities to which the invention will be applied are essentially closed systems, the overall flow rate can be set by fixing either the inflow rate or the outflow rate at a given value.
Intra-cavity pressure is a function of net liquid removed or added to the cavity. When inflow exceeds outflow, the pressure will rise. Conversely, when the inflow rate is less than the outflow, pressure will fall. Hence, in the presence of constant outflow, the inflow pump rate may be varied as part of feedback loop with intracavity pressure as the controlled variable and pump rate as the manipulated variable to produce the desired pressure within the cavity.
Compliance Monitoring
The disclosed invention allows for the automated measurement of compliance within a body cavity. Compliance is the change in pressure per unit of volume added to a cavity's contents, often expressed as the inverse of this ratio in units of ml/mmHg. In the intracranium, for example, normal compliance values are in the range 0.5-1.4 ml/mmHg. Compliance falls when organ swelling in response to injury occurs. Both high intracranial pressure and low compliance predict adverse outcome, but critical compliance changes tend to precede critical intracranial pressure changes, making compliance the preferred means of monitoring brain swelling. The disclosed invention can monitor compliance by periodically stopping both inflow and outflow, then delivering a known volume of liquid into the ventricle (running the inflow pump in the forward direction or the outflow pump in the reverse direction for a defined time at a defined rate) and recording the pressure response. Periodic compliance monitoring using reversed flow from the outflow pump has the additional benefit of periodically clearing the outflow port of the primary catheter of debris that may be drawn into this port by suction. Compliance monitoring is incorporated into the preferred embodiment of the invention as a means of monitoring effects on organs within a body cavity during rewarming, as some organs, such as the brain, are known to respond to rewarming with swelling due to reactive hyperemia. Decreased compliance during the rewarming process is used as a signal to slow or temporarily reverse the rate of rewarming.
Placement of the catheters
Fig. 3 shows schematic anatomical diagrams of human head and torso in lateral transparent view depicting a variety of possible catheter placement sites for the primary catheter insertion tip 8A. Figure 3A shows suitable placements in the peritoneum 28, the pleural space 27, and in the ventricular system (lateral ventricle preferred) of the brain 26. These are three important cavities in which continuous recirculation of a liquid at controlled temperatures and pressures with removal of contaminants and/or addition of drugs could be therapeutically useful. A solution of chemotherapy agents, for example, could be recirculated at these locations at a temperature higher than body temperature for the treatment of cancer. Catheter access (usually for the placement of passive drainage catheters) to each of these sites is routine for those skilled in the appropriate areas of medicine. Another cavity amenable to catheterization for this purpose is the mediastinum (not visible in Figure 3). The catheter can also be placed in other body cavities where heating or cooling, or removal of contaminants or insertion of drugs is desirable.
Figure 3B shows placement suitable for spinal cord injury. The insertion tip 8A of primary catheter 8 is depicted in the subarachnoid space at 29 C1-C2 (cervical vertebrae one and two, while the secondary drainage catheter 8 is located in the lumbar cistern 30. An artificial cerebrospinal solution at low temperature, for example, could be recirculated in these locations for hypothermic therapy in the case of spinal cord injury. Fig. 3C depicts an arrangement in which the insertion tip 8A of the primary catheter 8 is inserted into one of the lateral ventricles at 31 , while the secondary catheter 8 is inserted in the C1-C2 subarachnoid space at 32. This arrangement is intended to promote optimal temperature modulation in the distal brainstem and cerebellum by means of recirculated artificial cerebrospinal solution, for example, at low temperature. Automated Operation
In a particularly desirable embodiment, automated control of the system is achieved by means of computer 141 running a program of feedback loops based on sensor inputs and control outputs. In the preferred automated embodiment, computer 141 provides the interface with the user and can download programmed instructions to the hardware via digital-to- analog/analog-to-digital (DAC/ADC) conversion as shown schematically at 190, 191.
Inputs to the control system include: the temperature and pressure in the body cavity (from sensors 171 and 173), the temperature of the liquid emerging from the secondary catheter (if present), from sensor 102, the temperature of the conditioning chamber (from thermocouple 105), the status of the chiller/heater unit 14, and the status of battery backup power supply (not shown, but preferred to be present). Outputs from the computer-based control system include: on/off, rate and pumping direction of the pumps 5 and 16 for the primary catheter, on/off, rate and pumping direction of the pump 13 for the secondary catheter (if present), and heat/cool and power level of the heating/cooling elements 14.
Feedback Loops
Several concurrent closed feedback loops are desirable for the automated operation of the system. In the preferred automated embodiment, these are PID (proportion integration derivative) tuned feedback loops. The following loops are disclosed: 1. Chiller/heater drive vs. intracavity temperature: In the preferred embodiment, the temperature of the liquid in the conditioning chamber is measured by means of a thermocouple sensor 105 in contact with the chamber. The temperature of the intracavity temperature as sensed at the primary catheter by thermocouple 173 serves as the controlled variable, while the cooling/heating activity of the chiller/heater 14 is the manipulated variable.
2. Outflow vs. intracavity-chamber temperature differential: Sufficient circulation of liquid between the conditioning chamber 7 and the cavity 35 is achieved when the temperatures at these two locations approach one another closely. Outflow from the primary catheter through barrel 18 is adjusted based on the difference in temperature between the cavity 35 and the chamber 7 such that flow is increased until this difference reaches a preset minimum. The controlled variable is the intracavity-chamber temperature difference, and the manipulated variable is the rate of the outflow pump 5.
3. Inflow vs. Pressure: Inflow from the primary catheter through barrel 19 is increased if the intra-cavity pressure is below the desired value and decreased if it is above the desired value. In the preferred embodiment, the controlled variable is intracavity pressure measured by strain gauge 171 , while the manipulated variable is the rate of pump 16. An equivalent arrangement may obtained by reversing the roles of the pumps. A number of functionally equivalent schemes for the simultaneous control of temperature and pressure using the concept of bias flow or deltaflow (the difference between inflow and outflow rates) will be evident to one skilled in the art and are intended to be within the scope of the invention.
4. Outflow of the secondary catheter 1 vs. temperature of liquid emerging from the secondary catheter: Outflow from the optional secondary catheter is adjusted based on the temperature of the liquid as measured by sensor 102 at some point within the outflow pathway. The flow rate is increased until the temperature comes to within a desired range of the temperature at the primary catheter to ensure adequate distribution of liquid to the extremity of cavity in the region of the secondary catheter. In the preferred embodiment, the liquid temperature is measured within the secondary catheter at 102, and the flow rate is manually controlled by raising or lowering a gravity-based drain kit 2. An automated version of this control loop is disclosed in which the flow rate through the secondary catheter is controlled by means of a pump 132. In the automated version, drain kit 2 is removed.
Temperature/Pressure Control Profiles
The automated system can execute a defined sequence of temperature and pressure manipulations over long periods (hours to days) according to preset or user-defined temperature and pressure profiles.
Safety Features
A number of safety features can be incorporated into the preferred embodiment of the automated system of the invention. Preferably, power to the system is backed up by means of an uninterruptible power supply (not shown) which can maintain the operation of critical systems in the event of temporary disconnection from or failure of the mains supply. In the event of a non-recoverable failure of the computer, control of the pumps can preferably be switched to manual operation.
Suitably, the control software preferably includes a blockage detection routine that monitors the cavity pressure for loss of pressure control (intracavity pressure outside preset limits) and tests the catheters individually by measuring the pressure response to small volumes of liquid removed or added to the cavity. If the expected changes in pressure do not occur (rise in pressure in response to liquid added or a fall in pressure in response to liquid removed), then a blockage condition at the catheter is diagnosed. Four blockage conditions may occur: blockage of the outflow lumen in the OUT direction, blockage of the outflow lumen in the IN direction, blockage of the inflow lumen in the OUT direction, and blockage of the inflow lumen in the IN direction. These conditions preferably trigger a clearance routine in which flow is temporarily reversed in the affected catheter to clear debris. Total blockage in both the IN and OUT direction of a lumen that fails to clear is a non- recoverable condition that triggers an alarm signaling the need for operator intervention. Pump motor failure or blockage of either inflow in both lumens or outflow in both lumens is also non-recoverable. Blockage of outflow in one lumen and/or inflow in the other, however, is recoverable by reversal of flow through the two lumens.
If desired, equipment and control systems can be twinned for further safety.
Thus, two computerized control systems can be operated so that the failure of one can be compensated by the other, and or two chillers can be operated in parallel. Electrical contact circuits can also be used to monitor the connection status of the different parts of the system.
Example
An arrangement as shown in Figure 1 was used to remove cerebrospinal fluid and return a mixture of cerebrospinal fluid and artificial cerebrospinal fluid cooled to approximately 2°C in an adolescent pig (40 lbs). The animal was intubated and monitored under general anaesthesia. Rectal body temperature was controlled at 37°C using a heating pad. The primary catheter was inserted into the right lateral ventricle while a temperature probe was inserted into the brain parenchyma on the opposite side of the brain (left parietooccipital region). The indicated flow rates were produced by varying the speed of the outflow pump 5 and intracranial pressure was adjusted by controlling the speed of the inflow pump 8.
The results of three runs at different flow rates are presented in Figure 4. For each run, the intracranial pressure (ICP) in millimetres of mercury is shown as white circles and the temperature of the left parietooccipital region of the brain in degrees Celsius is shown as black circles. The flow rates were Figure 4A - 44 mL/min, Figure 4B 150 mL/min and Figure 4C -168 mL/min. As shown, higher flow rates and greater ICP's led to faster brain cooling in the presence of normal rectal temperatures. Therapeutic temperatures (<33°C) could be attained within 15 min without any perturbations in rectal body temperature. Indeed, in the third trial, the brain temperature dropped to 24 degrees Celsius in less than 20 minutes.
It will be understood that the present disclosure teaches presently preferred embodiments of the invention, and that modifications to such embodiments will be evident to one skilled in the art. Such modifications are intended to be within the scope of the invention, and the claims are to be read as including them.

Claims

What is claimed is:
1. Apparatus for modulating the temperature and pressure within a body cavity by means of recirculation of a biological or biocompatible liquid within the cavity, but outside of blood vessels, which comprises:
(a) first pump means for infusing liquid at a controlled temperature and flow rate into the cavity;
(b) means for monitoring the temperature within the cavity; (c) means for monitoring the pressure within the cavity; and
(d) second pump means for withdrawing liquid at a controlled flow rate from the cavity.
2. Apparatus as claimed in claim 1 , additionally comprising a dual lumen catheter insertable into said cavity, one lumen being connected to said first pump means and the second lumen being connected to said second pump means.
3. Apparatus as claimed in claims 1 or 2, comprising a further catheter insertable into said cavity to withdraw liquid from said cavity.
4. Apparatus as claimed in claim 3, in which said further catheter has associated pump means to withdraw liquid from said cavity.
5. Apparatus as claimed in claim 3, in which said further catheter has associated flow control means to regulate the flow of liquid from said cavity.
6. Apparatus as claimed in any of claims 1-5 including liquid storage means to receive liquid from said first pump means and to deliver liquid to said second pump means.
7. Apparatus as claimed in claim 6, in which said liquid storage means also receives liquid from said further catheter.
8. Apparatus as claimed in claim 6 or 7, in which said liquid storage means includes means to oxygenate liquid.
9. Apparatus as claimed in any of claims 7-9, in which said liquid storage means includes means to adjust the pH of the liquid.
10. Apparatus as claimed in any of claims 7-10, in which said liquid storage means includes means to separate contaminants from the liquid by foam fractionation.
11. Apparatus as claimed in any of claims 1-10, additionally comprising control means for at least one said pump means to control the operation of said pump means dependant on the output of said means for monitoring pressure and temperature within the cavity.
12. Apparatus as claimed in any of claims 6-10, additionally comprising:
(a) means for monitoring liquid temperature in the liquid storage means; and
(b) means for controlling said second pump means to control the operation of said pump means responsive to the difference between the temperature monitored by the means for monitoring the temperature within the cavity and the means for monitoring the liquid temperature in the liquid storage means.
13. Apparatus as claimed in any of claims 1-10, additionally comprising means responsive to the pressure sensed by said pressure monitoring means within the cavity to control operation of said first pump means.
14. A device for the continuous removal of contaminants from a biological or biocompatible liquid drawn from a body cavity which comprises:
(a) means for withdrawing the liquid from the body cavity; (b) pump means for applying suction to withdraw liquid from the body cavity;
(c) liquid storage means into which said pump means discharge liquid; (d) gas diffusion means to diffuse gas within such liquid into close contact with said liquid, whereby contaminants make a foam with such gas; and
(e) means for removing the foam from the surface of the liquid.
15. Apparatus as claimed in claim 14, wherein the means for removing foam from the liquid is a baffle positioned so that the foam will overflow it, and the liquid will substantially not overflow it.
16. A double lumen cylindrical catheter for recirculation of liquid within a body cavity:
(a) said catheter being divided longitudinally internally into a first and a second "D"-shaped lumen;
(b) having a closed distal tip in the shape of a rounded point and one or more apertures in the sides of each of the lumens near the distal tip which allow each of said lumens to communicate with the cavity when the catheter is inserted into the cavity; and
(c) having at its proximal end, separate connecting means for each said D-shaped lumen to fluid transport means.
17. A catheter as claimed in claim 13, additionally comprising a groove on its exterior adjacent its distal end, pressure sensing means located in said groove for sensing pressure in the cavity, temperature sensing means located in the groove for sensing temperature in the cavity, and means for reporting the values sensed by said pressure sensing means and said temperature sensing means to a location external to the cavity.
PCT/CA2003/001732 2002-11-12 2003-11-12 Device for the extravascular recirculation of liquid in body cavities WO2004043313A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2003281888A AU2003281888A1 (en) 2002-11-12 2003-11-12 Device for the extravascular recirculation of liquid in body cavities
US10/523,857 US7842002B2 (en) 2002-11-12 2003-11-12 Device for the extravascular recirculation of liquid in body cavities
US12/916,076 US20110046547A1 (en) 2002-11-12 2010-10-29 Device for the Extravascular Recirculation of Liquid in Body Cavities

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2,411,569 2002-11-12
CA002411569A CA2411569A1 (en) 2002-11-12 2002-11-12 Medical device for the extravascular recirculation of fluid in body cavities at controlled temperature and pressure

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/916,076 Continuation US20110046547A1 (en) 2002-11-12 2010-10-29 Device for the Extravascular Recirculation of Liquid in Body Cavities

Publications (2)

Publication Number Publication Date
WO2004043313A2 true WO2004043313A2 (en) 2004-05-27
WO2004043313A3 WO2004043313A3 (en) 2004-07-29

Family

ID=32304009

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2003/001732 WO2004043313A2 (en) 2002-11-12 2003-11-12 Device for the extravascular recirculation of liquid in body cavities

Country Status (4)

Country Link
US (2) US7842002B2 (en)
AU (1) AU2003281888A1 (en)
CA (1) CA2411569A1 (en)
WO (1) WO2004043313A2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008076814A2 (en) 2006-12-13 2008-06-26 Cincinnati Sub-Zero Products, Inc. Fluid disinfection unit for patient temperature control system
EP1971378A2 (en) * 2005-10-21 2008-09-24 Ceeben Systems, Inc. Method and apparatus for peritoneal hypothermia and/or resuscitation
EP2320987A1 (en) * 2008-07-29 2011-05-18 Medtronic, Inc. Apheresis of a target molecule from cerebrospinal fluid
EP2540260A1 (en) * 2010-02-22 2013-01-02 National University Corporation Okayama University Brain cooling apparatus and brain cooling device suitable thereto
WO2013044243A1 (en) 2011-09-22 2013-03-28 Arqos Surgical, Inc. Surgical fluid management systems and methods
EP3827841A1 (en) * 2006-10-09 2021-06-02 Neurofluidics, Inc. Cerebrospinal fluid purification system
CN112915297A (en) * 2021-01-22 2021-06-08 四川省人民医院 Recyclable urinary surgery flusher
US11883626B2 (en) 2019-06-27 2024-01-30 Boston Scientific Scimed, Inc. Detection of an endoscope to a fluid management system

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7699799B2 (en) * 2005-08-26 2010-04-20 Ceeben Systems, Inc. Ultrasonic material removal system for cardiopulmonary bypass and other applications
US20070051409A1 (en) 2005-09-02 2007-03-08 Belmont Instrument Corporation Pressure responsive fluid flow control valves
US20180311071A1 (en) * 2005-10-21 2018-11-01 Daniel R. BURNETT Method and apparatus for peritoneal oxygenation
US10850235B2 (en) 2006-10-09 2020-12-01 Minnetronix, Inc. Method for filtering cerebrospinal fluid (CSF) including monitoring CSF flow
US10569064B2 (en) * 2013-03-13 2020-02-25 Minnetronix, Inc. Devices and methods for providing focal cooling to the brain and spinal cord
US10632237B2 (en) 2006-10-09 2020-04-28 Minnetronix, Inc. Tangential flow filter system for the filtration of materials from biologic fluids
JP2010522066A (en) * 2007-03-23 2010-07-01 サーマル セラピューティク システムズ、インク. Mobile thermotherapy device
AU2008237177A1 (en) 2007-04-05 2008-10-16 Velomedix, Inc Automated therapy system and method
JP5410423B2 (en) * 2007-07-09 2014-02-05 ベロメディックス,インク Hypothermia apparatus and method
US7819835B2 (en) 2007-08-07 2010-10-26 Belmont Instrument Corporation Hyperthermia, system, method and components
US11000407B2 (en) 2007-08-07 2021-05-11 Belmont Instrument, Llc Hyperthermia, system, method, and components
US20090131857A1 (en) * 2007-11-20 2009-05-21 Mark Geiger Method and apparatus for introducing a medicinal dose directly into a mammalian patient's cerebrospinal fluid
US8366758B2 (en) * 2008-02-11 2013-02-05 The Regents Of The University Of California Hypothermia for improving rate of functional recovery following pelvic surgeries
WO2010054312A1 (en) * 2008-11-07 2010-05-14 Velomedix, Inc. Devices and methods for monitoring core temperature and an intraperitoneal parameter
CA2750473A1 (en) * 2009-02-06 2010-08-12 Velomedix, Inc. Method and apparatus for inducing therapeutic hypothermia
US8905968B2 (en) 2009-04-29 2014-12-09 Encephalon Technologies, Llc System for cooling and pressurizing fluid
US20100280438A1 (en) * 2009-04-29 2010-11-04 Dr. Jeffrey E. Thomas Bidirectional cerebral spinal fluid infusion catheter with cooling mechanism and method of use
WO2012006625A2 (en) 2010-07-09 2012-01-12 Velomedix, Inc. Method and apparatus for pressure measurement
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
EP2688602B1 (en) * 2011-03-23 2019-11-06 NxStage Medical, Inc. Peritoneal dialysis systems, devices, and methods
US20130146541A1 (en) 2011-12-13 2013-06-13 Nxstage Medical, Inc. Fluid purification methods, devices, and systems
CN105358207B (en) 2013-01-22 2018-12-28 安嫩西亚公司 System and method for shunting fluid
WO2015161306A1 (en) 2014-04-18 2015-10-22 Alcyone Lifesciences, Inc. Systems and methods for shunting fluid
EP3193976A1 (en) 2014-09-15 2017-07-26 Sanofi Providing temperature-based feedback regarding delivery of a medicament
US11147540B2 (en) 2015-07-01 2021-10-19 Minnetronix, Inc. Introducer sheath and puncture tool for the introduction and placement of a catheter in tissue
JP6619575B2 (en) * 2015-07-23 2019-12-11 日機装株式会社 Blood purification equipment
CN108778355B (en) 2015-12-04 2021-04-30 米奈特朗尼克斯有限公司 Systems and methods for regulating cerebrospinal fluid
AU2017342354A1 (en) 2016-10-13 2019-05-30 Anuncia, Inc. Shunt flushers and related methods
US20200046548A1 (en) * 2016-10-31 2020-02-13 Elmedix Bvba Whole-body hyperthermia system
US10137257B2 (en) 2016-11-30 2018-11-27 Belmont Instrument, Llc Slack-time heating system for blood and fluid warming
US10485936B2 (en) 2016-11-30 2019-11-26 Belmont Instrument, Llc Rapid infuser with advantageous flow path for blood and fluid warming
US10507292B2 (en) 2016-11-30 2019-12-17 Belmont Instrument, Llc Rapid infuser with vacuum release valve
WO2018188710A1 (en) * 2017-04-10 2018-10-18 Coloplast A/S Irrigation system with pressure sensing and control
US11179516B2 (en) 2017-06-22 2021-11-23 Baxter International Inc. Systems and methods for incorporating patient pressure into medical fluid delivery
US10849787B2 (en) * 2017-09-15 2020-12-01 Rohit Khanna Method and apparatus for treating the brain and/or spinal cord using a catheter
CA3092575A1 (en) 2018-02-28 2019-09-06 Nxstage Medical, Inc. Fluid preparation and treatment devices, methods, and systems
CA3138706A1 (en) * 2019-05-23 2020-11-26 Nxstage Medical, Inc. Medicament preparation devices, methods, and systems
CN113350598A (en) * 2021-04-07 2021-09-07 刘成一 Extracorporeal circulation treatment apparatus
CN114099803A (en) * 2021-11-25 2022-03-01 南方医科大学珠江医院 Intelligent thoracic drainage device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883459A (en) * 1983-07-29 1989-11-28 Reynaldo Calderon Retrograde perfusion
WO2001039819A2 (en) * 1999-12-03 2001-06-07 Neuron Therapeutics, Inc. Method and apparatus for closed recirculation of synthetic cerebrospinal fluid
WO2001058509A1 (en) * 2000-02-10 2001-08-16 Baxter International Inc. Method and apparatus for monitoring and controlling peritoneal dialysis therapy
US20020033181A1 (en) * 2000-01-14 2002-03-21 Groth Karl Emil Treatment of hepatitis C using hyperthermia

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2078786A (en) * 1934-12-17 1937-04-27 Wood Glen Mason Applicator and control means therefor
US3505988A (en) * 1967-04-11 1970-04-14 Norman Deane Prosthesis for chronic access to the peritoneum
US3927980A (en) * 1973-08-22 1975-12-23 Baxter Laboratories Inc Oxygen overpressure protection system for membrane-type blood oxygenators
US4445500A (en) 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4424806A (en) * 1981-03-12 1984-01-10 Physio-Control Corporation Automated ventilation, CPR, and circulatory assistance apparatus
US4450841A (en) * 1982-03-03 1984-05-29 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4497324A (en) * 1983-10-03 1985-02-05 American Hospital Supply Corporation Temperature monitoring catheter
IL78756A0 (en) * 1986-05-12 1986-08-31 Biodan Medical Systems Ltd Catheter and probe
US4808157A (en) * 1987-07-13 1989-02-28 Neuro Delivery Technology, Inc. Multi-lumen epidural-spinal needle
US4919134A (en) * 1987-07-31 1990-04-24 Becton, Dickinson And Company Thermoelectric chiller and automatic syringe
US4904237A (en) * 1988-05-16 1990-02-27 Janese Woodrow W Apparatus for the exchange of cerebrospinal fluid and a method of treating brain and spinal cord injuries
US5108364A (en) * 1989-02-16 1992-04-28 Sumitomo Bakelte Company Limited Monitoring catheter for medical use
US5141493A (en) 1990-01-26 1992-08-25 Sarcos Group Peritoneal dialysis system
US5395342A (en) * 1990-07-26 1995-03-07 Yoon; Inbae Endoscopic portal
US5584804A (en) * 1990-10-10 1996-12-17 Life Resuscitation Technologies, Inc. Brain resuscitation and organ preservation device and method for performing the same
US5149321A (en) * 1990-10-10 1992-09-22 Klatz Ronald M Brain resuscitation device and method for performing the same
US5122267A (en) 1991-01-24 1992-06-16 Oceanic Systems, Inc. Foam fractionation filter
WO1993020876A1 (en) * 1992-04-14 1993-10-28 Du-Med B.V. Electronic catheter displacement sensor
US5282962A (en) 1992-07-17 1994-02-01 Chen Chi Der Protein skimmer and power head thereof
US6620188B1 (en) * 1998-08-24 2003-09-16 Radiant Medical, Inc. Methods and apparatus for regional and whole body temperature modification
US6346074B1 (en) * 1993-02-22 2002-02-12 Heartport, Inc. Devices for less invasive intracardiac interventions
US5623940A (en) * 1994-08-02 1997-04-29 S.L.T. Japan Co., Ltd. Catheter apparatus with a sensor
US5554280A (en) 1995-05-15 1996-09-10 Loehr; Gary Filter system
US5562821A (en) * 1995-07-21 1996-10-08 Commonwealth Of Puerto Rico Foam fractionator
US5730720A (en) * 1995-08-18 1998-03-24 Ip Scientific, Inc. Perfusion hyperthermia treatment system and method
US5755756A (en) * 1995-09-15 1998-05-26 Freedman, Jr.; Robert J. Hypothermia-inducing resuscitation unit
US5665227A (en) 1995-11-29 1997-09-09 Watt; Ronald Dual-flow protein skimmer
US6066163A (en) * 1996-02-02 2000-05-23 John; Michael Sasha Adaptive brain stimulation method and system
JP3526690B2 (en) * 1996-04-26 2004-05-17 富雄 太田 Extracorporeal circulation device for separate cooling method
US6409699B1 (en) 1996-10-22 2002-06-25 Renal Solutions, Inc. Continuous flow-through peritoneal dialysis (CFPD) method with control of intraperitoneal pressure
US6019729A (en) * 1996-11-15 2000-02-01 Kabushiki Kaisha Tokai-Rika-Denki-Seisakusho Sensor mechanism-equipped catheter
JPH11221229A (en) * 1997-09-24 1999-08-17 Eclipse Surgical Technol Inc Catheter
US5916153A (en) * 1997-10-27 1999-06-29 Rhea, Jr.; W. Gardner Multifunction catheter
US7371254B2 (en) * 1998-01-23 2008-05-13 Innercool Therapies, Inc. Medical procedure
US6464716B1 (en) * 1998-01-23 2002-10-15 Innercool Therapies, Inc. Selective organ cooling apparatus and method
US6471717B1 (en) * 1998-03-24 2002-10-29 Innercool Therapies, Inc. Selective organ cooling apparatus and method
US6261312B1 (en) * 1998-06-23 2001-07-17 Innercool Therapies, Inc. Inflatable catheter for selective organ heating and cooling and method of using the same
US6599312B2 (en) * 1998-03-24 2003-07-29 Innercool Therapies, Inc. Isolated selective organ cooling apparatus
US6520933B1 (en) * 1998-04-21 2003-02-18 Alsius Corporation Central venous line cooling catheter having a spiral-shaped heat exchange member
US6581403B2 (en) * 2001-09-25 2003-06-24 Alsius Corporation Heating/cooling system for indwelling heat exchange catheter
US6716236B1 (en) * 1998-04-21 2004-04-06 Alsius Corporation Intravascular catheter with heat exchange element having inner inflation element and methods of use
US6530946B1 (en) * 1998-04-21 2003-03-11 Alsius Corporation Indwelling heat exchange heat pipe catheter and method of using same
US7287398B2 (en) * 2001-09-25 2007-10-30 Alsius Corporation Heating/cooling system for indwelling heat exchange catheter
US6682551B1 (en) * 1999-03-11 2004-01-27 Alsius Corporation Method and system for treating cardiac arrest using hypothermia
US6338727B1 (en) * 1998-08-13 2002-01-15 Alsius Corporation Indwelling heat exchange catheter and method of using same
US6368304B1 (en) * 1999-02-19 2002-04-09 Alsius Corporation Central venous catheter with heat exchange membrane
US6056766A (en) * 1998-06-09 2000-05-02 Thompson; Ronald J. Stabilized trocar, and method of using same
US6175688B1 (en) * 1998-07-10 2001-01-16 Belmont Instrument Corporation Wearable intravenous fluid heater
US6673098B1 (en) * 1998-08-24 2004-01-06 Radiant Medical, Inc. Disposable cassette for intravascular heat exchange catheter
US6620189B1 (en) * 2000-02-28 2003-09-16 Radiant Medical, Inc. Method and system for control of a patient's body temperature by way of a transluminally insertable heat exchange catheter
EP1119394A4 (en) * 1998-09-11 2004-07-07 Medivance Inc Method and apparatus for providing localized heating of the preoptic anterior hypothalamus
EP1616543B1 (en) * 1999-01-04 2008-09-03 Medivance Incorporated Improved cooling/heating pad and system
US6197045B1 (en) * 1999-01-04 2001-03-06 Medivance Incorporated Cooling/heating pad and system
US6743218B2 (en) * 1999-01-15 2004-06-01 Cathlogic, Inc. Retractable catheter systems and associated methods
US6436295B2 (en) 1999-02-11 2002-08-20 Jason Kim Protein skimmer
US6405080B1 (en) * 1999-03-11 2002-06-11 Alsius Corporation Method and system for treating cardiac arrest
US6554797B1 (en) * 1999-02-19 2003-04-29 Alsius Corporation Method and system for patient temperature management and central venous access
US6582398B1 (en) * 1999-02-19 2003-06-24 Alsius Corporation Method of managing patient temperature with a heat exchange catheter
US6719724B1 (en) * 1999-02-19 2004-04-13 Alsius Corporation Central venous line catheter having multiple heat exchange elements and multiple infusion lumens
US6254567B1 (en) 1999-02-26 2001-07-03 Nxstage Medical, Inc. Flow-through peritoneal dialysis systems and methods with on-line dialysis solution regeneration
US6217552B1 (en) 1999-03-01 2001-04-17 Coaxia, Inc. Medical device for selective intrathecal spinal cooling in aortic surgery and spinal trauma
US6019783A (en) * 1999-03-02 2000-02-01 Alsius Corporation Cooling system for therapeutic catheter
US6579496B1 (en) * 1999-05-25 2003-06-17 Viacirq, Inc. Apparatus for implementing hyperthermia
US6547811B1 (en) * 1999-08-02 2003-04-15 Arch Development Corporation Method for inducing hypothermia
US6231594B1 (en) * 1999-08-11 2001-05-15 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering
US6554791B1 (en) * 1999-09-29 2003-04-29 Smisson-Cartledge Biomedical, Llc Rapid infusion system
US6648906B2 (en) * 2000-04-06 2003-11-18 Innercool Therapies, Inc. Method and apparatus for regulating patient temperature by irrigating the bladder with a fluid
US6726708B2 (en) * 2000-06-14 2004-04-27 Innercool Therapies, Inc. Therapeutic heating and cooling via temperature management of a colon-inserted balloon
US6530945B1 (en) * 2000-11-28 2003-03-11 Alsius Corporation System and method for controlling patient temperature
US6699268B2 (en) * 2000-12-15 2004-03-02 Alsius Corporation Radio frequency patient heating system
US6529775B2 (en) * 2001-01-16 2003-03-04 Alsius Corporation System and method employing indwelling RF catheter for systemic patient warming by application of dielectric heating
US6709448B2 (en) * 2001-04-13 2004-03-23 Alsius Corporation Open core heat exchange catheter, system and method
US6706060B2 (en) * 2001-06-05 2004-03-16 Alsius Corporation Heat exchange catheter
US6733517B1 (en) * 2001-06-13 2004-05-11 Alsius Corporation Angling introducer sheath for catheter having temperature control system
US6912416B2 (en) * 2001-07-18 2005-06-28 Peter L. Rosenblatt Detecting or preventing tissue damage
US6676409B2 (en) * 2001-08-01 2004-01-13 Medivance Instruments Limited Dental tool
US6692519B1 (en) * 2001-08-06 2004-02-17 Radiant Medical, Inc. Use of endovascular hypothermia in organ and/or tissue transplantations
US6607517B1 (en) * 2001-08-24 2003-08-19 Radiant Medical, Inc. Method of inotropic treatment of heart disease using hypothermia
US6827702B2 (en) * 2001-09-07 2004-12-07 Medtronic Minimed, Inc. Safety limits for closed-loop infusion pump control
US6699267B2 (en) * 2001-10-11 2004-03-02 Medivance Incorporated Patient temperature control system with fluid temperature response
CA2464525C (en) * 2001-10-24 2012-01-10 Pressure Profile Systems, Inc. Array sensor electronics
US6603997B2 (en) * 2001-11-02 2003-08-05 Michael C. Doody Probe penetration detector and method of operation
US6572640B1 (en) * 2001-11-21 2003-06-03 Alsius Corporation Method and apparatus for cardiopulmonary bypass patient temperature control
US6692518B2 (en) * 2002-02-27 2004-02-17 Medivance Incorporated Patient temperature control system
US6704590B2 (en) * 2002-04-05 2004-03-09 Cardiac Pacemakers, Inc. Doppler guiding catheter using sensed blood turbulence levels
US6685733B1 (en) * 2002-04-10 2004-02-03 Radiant Medical, Inc. Methods and systems for reducing substance-induced renal damage
US7666213B2 (en) * 2002-07-11 2010-02-23 Life Recovery Systems Hd, Llc Apparatus for altering the body temperature of a patient
US6878156B1 (en) * 2002-07-26 2005-04-12 Alsius Corporation Portable cooler for heat exchange catheter
US20040039430A1 (en) * 2002-08-20 2004-02-26 Xanodyne Pharmacal, Inc. System and method using the rectal mucosal membrane for inducing hypothermia and warming
AU2003270600B2 (en) * 2002-09-12 2008-08-14 Radiant Medical, Inc. System and method for determining and controlling core body temperature
US6887263B2 (en) * 2002-10-18 2005-05-03 Radiant Medical, Inc. Valved connector assembly and sterility barriers for heat exchange catheters and other closed loop catheters
US20040087606A1 (en) * 2002-11-01 2004-05-06 Voorhees Marc E. Shivering suppression during cooling to lower body temperature
US20040122353A1 (en) * 2002-12-19 2004-06-24 Medtronic Minimed, Inc. Relay device for transferring information between a sensor system and a fluid delivery system
US6893454B2 (en) * 2003-04-28 2005-05-17 Alsius Corporation Intrarectal heat exchange catheter
US7001418B2 (en) * 2003-04-30 2006-02-21 Alsius Corporation Intravascular heat exchange catheter with insulated coolant tubes
US6872222B2 (en) * 2003-05-19 2005-03-29 Alsius Corporation System and method for insulating skin from intravascular heat exchange catheter
US20050033391A1 (en) * 2003-08-06 2005-02-10 Alsius Corporation System and method for treating cardiac arrest and myocardial infarction
CA2536810A1 (en) * 2003-08-25 2005-04-28 Medivance Incorporated Active body cooling with vasodilation to reduce body temperature
US7270639B2 (en) * 2003-10-14 2007-09-18 Zoll Circulation, Inc. Temperature regulation system for automatic chest compression housing
US7699799B2 (en) * 2005-08-26 2010-04-20 Ceeben Systems, Inc. Ultrasonic material removal system for cardiopulmonary bypass and other applications
US20070093697A1 (en) * 2005-10-21 2007-04-26 Theranova, Llc Method and apparatus for detection of right to left shunting in the cardiopulmonary vasculature
JP5410423B2 (en) * 2007-07-09 2014-02-05 ベロメディックス,インク Hypothermia apparatus and method
WO2010054312A1 (en) * 2008-11-07 2010-05-14 Velomedix, Inc. Devices and methods for monitoring core temperature and an intraperitoneal parameter

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883459A (en) * 1983-07-29 1989-11-28 Reynaldo Calderon Retrograde perfusion
WO2001039819A2 (en) * 1999-12-03 2001-06-07 Neuron Therapeutics, Inc. Method and apparatus for closed recirculation of synthetic cerebrospinal fluid
US20020033181A1 (en) * 2000-01-14 2002-03-21 Groth Karl Emil Treatment of hepatitis C using hyperthermia
WO2001058509A1 (en) * 2000-02-10 2001-08-16 Baxter International Inc. Method and apparatus for monitoring and controlling peritoneal dialysis therapy

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1971378A4 (en) * 2005-10-21 2013-10-02 Velomedix Inc Method and apparatus for peritoneal hypothermia and/or resuscitation
EP1971378A2 (en) * 2005-10-21 2008-09-24 Ceeben Systems, Inc. Method and apparatus for peritoneal hypothermia and/or resuscitation
US11065425B2 (en) 2006-10-09 2021-07-20 Neurofluidics, Inc. Cerebrospinal fluid purification system
EP3827841A1 (en) * 2006-10-09 2021-06-02 Neurofluidics, Inc. Cerebrospinal fluid purification system
EP2097053A4 (en) * 2006-12-13 2012-07-11 Cincinnati Sub Zero Products Inc Fluid disinfection unit for patient temperature control system
EP2097053A2 (en) * 2006-12-13 2009-09-09 Cincinnati Sub-Zero Products, Inc. Fluid disinfection unit for patient temperature control system
US8460353B2 (en) 2006-12-13 2013-06-11 Cincinnati Sub-Zero Products, Inc. Fluid disinfection unit for patient temperature control system
WO2008076814A2 (en) 2006-12-13 2008-06-26 Cincinnati Sub-Zero Products, Inc. Fluid disinfection unit for patient temperature control system
EP2320987A1 (en) * 2008-07-29 2011-05-18 Medtronic, Inc. Apheresis of a target molecule from cerebrospinal fluid
EP2540260A1 (en) * 2010-02-22 2013-01-02 National University Corporation Okayama University Brain cooling apparatus and brain cooling device suitable thereto
EP2540260A4 (en) * 2010-02-22 2015-02-18 Univ Okayama Nat Univ Corp Brain cooling apparatus and brain cooling device suitable thereto
US9901665B2 (en) 2011-09-22 2018-02-27 Boston Scientific Scimed, Inc. Surgical fluid management systems and methods
US10751451B2 (en) 2011-09-22 2020-08-25 Boston Scientific Scimed, Inc. Surgical fluid management systems and methods
EP2758115A4 (en) * 2011-09-22 2015-11-11 Iogyn Inc Surgical fluid management systems and methods
WO2013044243A1 (en) 2011-09-22 2013-03-28 Arqos Surgical, Inc. Surgical fluid management systems and methods
US11883626B2 (en) 2019-06-27 2024-01-30 Boston Scientific Scimed, Inc. Detection of an endoscope to a fluid management system
CN112915297A (en) * 2021-01-22 2021-06-08 四川省人民医院 Recyclable urinary surgery flusher
CN112915297B (en) * 2021-01-22 2022-09-23 四川省人民医院 Recyclable urinary surgery flusher

Also Published As

Publication number Publication date
WO2004043313A3 (en) 2004-07-29
US20060161107A1 (en) 2006-07-20
AU2003281888A1 (en) 2004-06-03
US20110046547A1 (en) 2011-02-24
US7842002B2 (en) 2010-11-30
CA2411569A1 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
US7842002B2 (en) Device for the extravascular recirculation of liquid in body cavities
US6918924B2 (en) Method and apparatus for regulating patient temperature by irrigating the bladder with a fluid
US20220280337A1 (en) Apparatus and method for providing enhanced heat transfer from a body
EP3685813B1 (en) Apparatus for extracorporeal support of premature fetus
US7241307B2 (en) Method and apparatus for managing temperature in a patient
WO1994017842A1 (en) Closed circulation tissue warming apparatus
US9314366B2 (en) Surgical heating and cooling system and devices and methods for the use thereof
AU2016203442B2 (en) Method for adjusting the temperature of a patient
AU2012211501B2 (en) Method for adjusting the temperature of a patient

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2006161107

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10523857

Country of ref document: US

122 Ep: pct application non-entry in european phase
WWP Wipo information: published in national office

Ref document number: 10523857

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP